30 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... Disease in HIV-AIDS ... #Prophylaxis #Opportunistic ... #OIs #HIVAIDS #IDSA
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... Disease in HIV-AIDS ... #Prophylaxis #Opportunistic ... #OIs #HIVAIDS #IDSA
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... known to have HIV ... diagnosed with HIV ... HumanPapillomavirus #IDSA ... Treatment #management #opportunistic
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... infection: typical cellulitis ... erysipelas with no focus ... #SSTIs #Algorithm ... #idsa
Atraumatic Red Eye - Differential Diagnosis Algorithm
Lids / Orbit / Lacrimal System:
 • Blepharitis
 • Stye
Differential Diagnosis Algorithm ... • Pre-septal cellulitis ... • Orbital Cellulitis ... Corneal Ulcer • HSV ... Differential #Diagnosis #Algorithm
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Infections in HIV-AIDS ... to 5 mg/kg/day IV ... Penicilliosis #IDSA ... Treatment #management #opportunistic
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Infections in HIV-AIDS ... PO (or 400 mg IV ... Enteric #Bacterial #IDSA ... Treatment #management #opportunistic
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Candidiasis in HIV-AIDS ... 400 mg) PO or IV ... candida #mucosal #IDSA ... Treatment #management #opportunistic
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... Leishmaniasis in HIV-AIDS ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... Treatment #management #opportunistic
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... Simplex Virus (HSV ... Infections in HIV-AIDS ... #IDSA #Prevention ... Treatment #management #opportunistic